Dr.DermMIA said:Orforglipron is the more interesting oral story because it is not a peptide at all.
This is exactly what I could not find anywhere else. I will report back once I have actually tried it.
Dr.DermMIA said:Orforglipron is the more interesting oral story because it is not a peptide at all.
This is exactly what I could not find anywhere else. I will report back once I have actually tried it.
Adding the clinical framing, because it changes how the question reads. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.
Dr.KarenChen said:Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…
This is where I part company with the consensus forming above. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsOne concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.